One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Access
PDF Availablehttps://doi.org/10.1093/annonc/mdy281.031
Copy DOI
Export
Save
Share
Cite Journal: Annals of Oncology |  Publication Date: Oct 1, 2018 |
 License type: publisher-specific-oa |
Affiliation: St. Marianna University School of Medicine, Kagawa University Hospital, Nihon University, Cancer Genetics (United States), Showa University, Ludwig-Maximilians-Universität München, Kitasato University, HTG Molecular Diagnostics (United States), University of Southern California, Showa University Fujigaoka Hospital, Chiba Cancer Center, Kite (United States)
483P - A biomarker study to validate predictors for clinical outcome of cetuximab based chemotherapy in first-line metastatic colorectal cancer (mCRC) patients: JACCRO CC-05/06AR and FIRE-3
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
